CIK 0000719135 · Non-accelerated filer<br>Smaller reporting company
Apyx Medical Corp
Sign in to watch- Ticker
- APYX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112644611
- Phone
- 7273842323
- Business address
- 5115 ULMERTON ROAD, CLEARWATER, FL, 33760
- Former names
- BOVIE MEDICAL CORP, BOVIE MEDICAL Corp, AN CON GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-11 | Waldman Lawrence Director | Option exercise | +24,000 | $2.54 | $61K | 37,563 |
| 2022-07-11 | Waldman Lawrence Director | Option exercise · Stock Option (Option to Buy) | −24,000 | 0 | ||
| 2022-07-06 | Geraghty Michael Director | Option exercise | +4,000 | $2.54 | $10K | 17,500 |
| 2022-07-06 | Geraghty Michael Director | Option exercise · Stock Option (Option to Buy) | −4,000 | 0 | ||
| 2022-07-05 | MAKRIDES ANDREW Director | Option exercise | +30,000 | $2.54 | $76K | 637,972 |
| 2022-07-05 | MAKRIDES ANDREW Director | Shares withheld for taxes | −13,583 | $6.14 | $83K | 624,389 |
| 2022-07-05 | MAKRIDES ANDREW Director | Option exercise · Stock Option (Option to Buy) | −30,000 | 0 | ||
| 2022-05-19 | Waldman Lawrence Director | Option exercise | +8,000 | $2.79 | $22K | 13,563 |
| 2022-05-19 | Waldman Lawrence Director | Option exercise · Stock Option (Option to Buy) | −8,000 | 0 | ||
| 2022-05-11 | Geraghty Michael Director | Option exercise | +6,000 | $2.79 | $17K | 13,500 |
| 2022-05-11 | Geraghty Michael Director | Option exercise · Stock Option (Option to Buy) | −6,000 | 0 | ||
| 2022-03-21 | Swandal Craig A. Director | Option exercise | +17,000 | $4.98 | $85K | 17,000 |
| 2022-03-21 | Swandal Craig A. Director | Option exercise · Stock Option (Option to Buy) | −17,000 | 0 | ||
| 2022-01-19 | Hornsby Todd Executive Vice President | Grant or award · Stock Option (Option to Buy) | +100,000 | 100,000 | ||
| 2022-01-19 | CITRONOWICZ MOSHE Sr. V.P. of Operations | Grant or award · Stock Option (Option to Buy) | +72,000 | 72,000 | ||
| 2022-01-19 | Goodwin Charles D. II Chief Executive Officer | Grant or award · Stock Option (Option to Buy) | +243,000 | 243,000 | ||
| 2022-01-19 | Semb Tara Chief Financial Officer | Grant or award · Stock Option (Option to Buy) | +96,000 | 96,000 | ||
| 2022-01-07 | Swandal Craig A. Director | Option exercise | +7,173 | $9.42 | $68K | 60,173 |
| 2022-01-07 | Swandal Craig A. Director | Option exercise · Stock Option (Option to Buy) | −7,173 | 0 | ||
| 2021-08-06 | Baylor-Henry Minnie Director | Grant or award · Stock Option (Option to Buy) | +17,000 | 17,000 |
Page 5 of 7 · 131 trades